Cite
Impact of eplerenone on major cardiovascular outcomes in patients with systolic heart failure according to baseline heart rate.
MLA
Chin, Ken Lee, et al. “Impact of Eplerenone on Major Cardiovascular Outcomes in Patients with Systolic Heart Failure According to Baseline Heart Rate.” Clinical Research in Cardiology, vol. 108, no. 7, July 2019, pp. 806–14. EBSCOhost, https://doi.org/10.1007/s00392-018-1410-4.
APA
Chin, K. L., Collier, T., Pocock, S., Pitt, B., McMurray, J. J. V., van Veldhuisen, D. J., Swedberg, K., Vincent, J., Zannad, F., & Liew, D. (2019). Impact of eplerenone on major cardiovascular outcomes in patients with systolic heart failure according to baseline heart rate. Clinical Research in Cardiology, 108(7), 806–814. https://doi.org/10.1007/s00392-018-1410-4
Chicago
Chin, Ken Lee, Timothy Collier, Stuart Pocock, Bertram Pitt, John J. V. McMurray, Dirk J. van Veldhuisen, Karl Swedberg, John Vincent, Faiez Zannad, and Danny Liew. 2019. “Impact of Eplerenone on Major Cardiovascular Outcomes in Patients with Systolic Heart Failure According to Baseline Heart Rate.” Clinical Research in Cardiology 108 (7): 806–14. doi:10.1007/s00392-018-1410-4.